Skip to main content
. 2014 Nov 13;14(1):135–144. doi: 10.1007/s10689-014-9769-5

Table 2.

Participant characteristics (n = 8)

Participant Age Genetic testing Genetic testing result Risk-reducing surgery Screening
BSO Mx
HROC_02 38 No Yes No No
HROC_03 42 Yes No mutation Yes No No
HROC_04 45 Yes No mutation Yes No Yes—until BSO
HROC_05 35 Yes BRCA2 +ve No Yes Yes
HROC_06 37 Yes BRCA1 +ve No No No
HROC_07 58 No No No Yes
HROC_08 29 Yes BRCA1 +ve No No No
HROC_10 25 Yes BRCA1 +ve No Yes No

BSO = bilateral salpingo-oophorectomy, Mx = mastectomy, Screening = transvaginal ultrasound and/or CA125 biomarker, +ve = mutation positive